AXA/2025/FY/Earnings presentation: Difference between revisions
Appearance
< AXA
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
| Line 24: | Line 24: | ||
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures === |
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures === |
||
* Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives |
* Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives <sup>p. 2</sup>. |
||
* Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' <sup>p. 2</sup>. |
|||
* Statements regarding expected '''underlying earnings per share''' ('UEPS') growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>. |
|||
* Statements regarding expected '''underlying earnings per share (UEPS) growth''' for 2026 are forward-looking, providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>. |
|||
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>. |
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>. |
||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties |
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA's control <sup>p. 2</sup>. |
||
* Factors could cause AXA's actual results to differ materially from those expressed or implied <sup>p. 2</sup>. |
|||
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>. |
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>. |
||
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>. |
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>. |
||
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>. |
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>. |
||
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and |
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and position <sup>p. 2</sup>. |
||
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>. |
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>. |
||
* |
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS <sup>p. 2</sup>. |
||
* '''Underlying earnings''', UEPS ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and |
* '''Underlying earnings''', '''UEPS''' ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and AMF's related position statement issued in 2015 <sup>p. 2</sup>. |
||
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>. |
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>. |
||
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>. |
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>. |
||
| Line 42: | Line 44: | ||
=== Table of contents === |
=== Table of contents === |
||
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on |
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on p.04 <sup>p. 3</sup>. |
||
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on |
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on p.09 <sup>p. 3</sup>. |
||
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on |
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on p.13 <sup>p. 3</sup>. |
||
== FY25 Highlights == |
== FY25 Highlights == |
||
* |
* Presented by Thomas Buberl, Group CEO <sup>p. 4</sup>. |
||
* Thomas Buberl, Group CEO <sup>p. 4</sup> |
|||
=== Full Year 2025 | Excellent performance === |
=== Full Year 2025 | Excellent performance === |
||
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup> |
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup> |
||
* '''ROE''' 16% in FY25 <sup>p. 5</sup> |
|||
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup> |
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup> |
||
* ''' |
* '''Solvency II ratio''' 224% in FY25 <sup>p. 5</sup> |
||
* ''' |
* Delivering value for shareholders with +8% '''DPS''' growth and EUR 1.25bn annual share buyback <sup>p. 5</sup> |
||
** '''Dividend''' proposed by AXA's Board of Directors on February 25, 2026, subject to approval by Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>. |
|||
* Delivering value for shareholders with '''DPS''' +8% growth and EUR 1.25bn annual share buy back <sup>p. 5</sup>. |
|||
** |
** '''Share buyback''' approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>. |
||
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup> |
|||
** The annual share buy back follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>. |
|||
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>. |
|||
=== Executing the plan on growth, margin and efficiency === |
=== Executing the plan on growth, margin and efficiency === |
||
| Line 66: | Line 67: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings |
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 76: | Line 77: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +6% <sup>p. 6</sup> |
|||
* |
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup> |
||
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup> |
|||
* Scaling the business: Continued investments in growth and technology <sup>p. 6</sup> |
|||
** Health: +5% <sup>p. 6</sup> |
|||
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup> |
|||
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup> |
|||
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup> |
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup> |
||
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup> |
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup> |
||
=== Diversified franchise, well positioned in an attractive industry === |
=== Diversified franchise, well positioned in an attractive industry === |
||
| Line 110: | Line 108: | ||
|} |
|} |
||
</div> |
</div> |
||
* Secular trends fueling demand across businesses <sup>p. 7</sup> |
|||
* Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup> |
|||
* '''Secular trends fueling demand across businesses''': <sup>p. 7</sup> |
|||
* Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup> |
|||
* Our right to win <sup>p. 7</sup> |
|||
** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup> |
|||
* |
* Leading brand & high customer NPS <sup>p. 7</sup> |
||
* Strong and diversified distribution <sup>p. 7</sup> |
|||
* Technical expertise to price & underwrite risks <sup>p. 7</sup> |
|||
* Scale offering cost advantage <sup>p. 7</sup> |
|||
** Scale offering cost advantage <sup>p. 7</sup> |
|||
* Pie chart represents FY25 gross written premium split excluding AXA IM and holdings <sup>p. 7</sup>. |
|||
=== Laying the foundation for the next plan === |
=== Laying the foundation for the next plan === |
||
| Line 130: | Line 126: | ||
== FY25 Business Performance == |
== FY25 Business Performance == |
||
=== - Guillaume Borie <sup>p. 9</sup> === |
|||
* Guillaume Borie <sup>p. 9</sup> |
* Guillaume Borie <sup>p. 9</sup> |
||
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup> |
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup> |
||
* FY25 Business Performance <sup>p. 9</sup> |
|||
=== Strong delivery across our businesses === |
=== Strong delivery across our businesses === |
||
| Line 141: | Line 134: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Gross written premiums and underlying earnings by region, FY25 <sup>p. 10</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | GWP % change |
|||
! class="col-s" style="text-align:right" | GWP |
! class="col-s" style="text-align:right" | GWP |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | GWP change |
||
! class="col-s" style="text-align:right" | Underlying earnings |
! class="col-s" style="text-align:right" | Underlying earnings |
||
! class="col-s" style="text-align:right" | Underlying earnings change |
|||
! class="col-s" style="text-align:right" | % of total GWP |
|||
|- |
|- |
||
| style="text-align:left" | France |
| style="text-align:left" | France |
||
| style="text-align:right" | +6% |
|||
| style="text-align:right" | 31 |
| style="text-align:right" | 31 |
||
| style="text-align:right" | + |
| style="text-align:right" | +6% |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | 27% |
|||
|- |
|- |
||
| style="text-align:left" | Europe |
| style="text-align:left" | Europe |
||
| style="text-align:right" | +6% |
|||
| style="text-align:right" | 43 |
| style="text-align:right" | 43 |
||
| style="text-align:right" | + |
| style="text-align:right" | +6% |
||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | +9% |
|||
| style="text-align:right" | 38% |
|||
|- |
|- |
||
| style="text-align:left" | AXA XL |
| style="text-align:left" | AXA XL |
||
| style="text-align:right" | +4% |
|||
| style="text-align:right" | 19 |
| style="text-align:right" | 19 |
||
| style="text-align:right" | + |
| style="text-align:right" | +4% |
||
| style="text-align:right" | 1.9 |
| style="text-align:right" | 1.9 |
||
| style="text-align:right" | +9% |
|||
| style="text-align:right" | 17% |
|||
|- |
|- |
||
| style="text-align:left" | Asia, Africa & EME-LATAM |
| style="text-align:left" | Asia, Africa & EME-LATAM |
||
| style="text-align:right" | +13% |
|||
| style="text-align:right" | 20 |
| style="text-align:right" | 20 |
||
| style="text-align:right" | + |
| style="text-align:right" | +13% |
||
| style="text-align:right" | 1.5 |
| style="text-align:right" | 1.5 |
||
| style="text-align:right" | +6% |
|||
| style="text-align:right" | 18% |
|||
|} |
|} |
||
</div> |
</div> |
||
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX |
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX |
||
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers |
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers |
||
* '''France''' (27% of total GWP¹): <sup>p. 10</sup> |
|||
* '''Europe''' (38% of total GWP¹): <sup>p. 10</sup> |
|||
* '''AXA XL''' (17% of total GWP¹): <sup>p. 10</sup> |
|||
* '''Asia, Africa & EME-LATAM''' (18% of total GWP¹): <sup>p. 10</sup> |
|||
=== P&C | Strong margins, confidence in sustaining growth === |
=== P&C | Strong margins, confidence in sustaining growth === |
||
| Line 184: | Line 178: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP split |
|+ GWP split, EUR 58bn total <sup>p. 11</sup> |
||
! style="text-align:left" | Segment |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
| Line 198: | Line 192: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +9% |
* Underlying earnings +9% (FY25 vs. FY24 at constant FX) to EUR 5.9bn |
||
* Includes AXA XL Re premiums of EUR 2.6bn |
|||
* (diagram) '''2025 Strategic Focus''' |
|||
* '''2025 Strategic Focus''' |
|||
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins |
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins |
||
** '''AXA XL''' (Large & Specialty): Profitable growth with stable margins |
** '''AXA XL''' (Large & Specialty): Profitable growth with stable margins |
||
* |
* '''Beyond 2025 Strategic Focus''' |
||
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint |
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint |
||
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management |
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management |
||
* |
* '''Additional Strategic Initiatives''' |
||
** Continued progress on efficiency |
** Continued progress on efficiency |
||
** Higher investment income |
** Higher investment income |
||
** Data & AI to further enhance customer experience & technical excellence |
** Data & AI to further enhance customer experience & technical excellence |
||
* '''AXA XL''' (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) <sup>p. 11</sup> |
|||
=== L&H | Good momentum, well positioned to capture growth opportunities === |
=== L&H | Good momentum, well positioned to capture growth opportunities === |
||
| Line 215: | Line 209: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP split |
|+ GWP split, EUR 57bn total <sup>p. 12</sup> |
||
! style="text-align:left" | Segment |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
| Line 226: | Line 220: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +7% |
* Underlying earnings +7% (FY25 vs. FY24 at constant FX) to EUR 3.5bn |
||
* |
* '''2025 Strategic Focus''' |
||
** '''Long-term business''': Accelerating net flows in Savings at attractive margins |
** '''Long-term business''': Accelerating net flows in Savings at attractive margins |
||
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact |
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact |
||
* |
* '''Beyond 2025 Strategic Focus''' |
||
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers |
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers |
||
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins |
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins |
||
* |
* '''Additional Strategic Initiatives''' |
||
** Focus on cost reduction |
** Focus on cost reduction |
||
** Increasing penetration of Protection riders in Savings offerings |
** Increasing penetration of Protection riders in Savings offerings |
||
| Line 240: | Line 234: | ||
== FY25 Financial Performance == |
== FY25 Financial Performance == |
||
* |
* FY25 Financial Performance <sup>p. 13</sup> |
||
* Alban de Mailly Nesle <sup>p. 13</sup> |
* Alban de Mailly Nesle, Group CFO <sup>p. 13</sup> |
||
* Group CFO <sup>p. 13</sup> |
|||
=== P&C | Continued disciplined growth === |
=== P&C | Continued disciplined growth === |
||
| Line 249: | Line 242: | ||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP & other revenues by line, FY24 vs FY25 <sup>p. 14</sup> |
|+ GWP & other revenues by line, FY24 vs FY25 <sup>p. 14</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| Line 270: | Line 263: | ||
|} |
|} |
||
</div> |
</div> |
||
* Commercial lines: +4% change (o/w pricing +2%, o/w volume +2%) <sup>p. 14</sup> |
|||
<div style="overflow-x:auto"> |
|||
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup> |
|||
{| class="wikitable fintable" |
|||
* AXA XL Reinsurance: +8% change (o/w pricing +0.3%, o/w volume +7%) <sup>p. 14</sup> |
|||
|+ Change at constant scope and FX <sup>p. 14</sup> |
|||
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup> |
|||
! style="text-align:left" | Segment |
|||
** Growth supported by alternative capital <sup>p. 14</sup> |
|||
! class="col-s" style="text-align:right" | Change |
|||
* Retail lines: +7% change (o/w pricing +5%, o/w volume +2%) <sup>p. 14</sup> |
|||
! class="col-s" style="text-align:right" | Pricing |
|||
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup> |
|||
! class="col-s" style="text-align:right" | Volume |
|||
* Change at constant scope and FX <sup>p. 14</sup> |
|||
|- |
|||
| style="text-align:left" | Commercial lines |
|||
| style="text-align:right" | +4% |
|||
| style="text-align:right" | +2% |
|||
| style="text-align:right" | +2% |
|||
|- |
|||
| style="text-align:left" | AXA XL Reinsurance |
|||
| style="text-align:right" | +8% |
|||
| style="text-align:right" | +0.3% |
|||
| style="text-align:right" | +7% |
|||
|- |
|||
| style="text-align:left" | Retail lines |
|||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | +5% |
|||
| style="text-align:right" | +2% |
|||
|} |
|||
</div> |
|||
* Continued pricing momentum and volume growth in Mid-market and SME |
|||
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance |
|||
* Growth supported by alternative capital |
|||
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) |
|||
* (table) '''Change at constant scope and FX''' <sup>p. 14</sup> |
|||
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
||
| Line 283: | Line 298: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Combined ratio |
|+ Combined ratio, FY24 vs FY25 <sup>p. 15</sup> |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 313: | Line 328: | ||
|} |
|} |
||
</div> |
</div> |
||
* Better undiscounted current year loss ratio excluding Nat Cat from: |
* Better undiscounted current year loss ratio excluding Nat Cat from: |
||
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment |
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment |
||
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management |
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management |
||
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology |
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology |
||
* Nat Cat charges below normalized load |
* Nat Cat charges below normalized load |
||
* Lower reliance on prior year reserve development |
* Lower reliance on prior year reserve development |
||
* Taking advantage of a good year to enhance reserve prudence |
* Taking advantage of a good year to enhance reserve prudence |
||
=== P&C | Earnings growth from higher underwriting and financial result === |
=== P&C | Earnings growth from higher underwriting and financial result === |
||
| Line 354: | Line 369: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying Earnings +9% ( |
* Underlying Earnings +9% (constant FX) |
||
* Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence |
* Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence |
||
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets |
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets |
||
* Higher unwind of discount of claims reserves, in line with guidance |
* Higher unwind of discount of claims reserves, in line with guidance |
||
* Unfavorable forex impact notably due to USD depreciation vs. EUR |
* Unfavorable forex impact notably due to USD depreciation vs. EUR |
||
=== Life & Health | Strong growth in premiums, positive net flows === |
=== Life & Health | Strong growth in premiums, positive net flows === |
||
| Line 364: | Line 379: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ GWP & other revenues by line, FY24 vs FY25 <sup>p. 17</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|||
| style="text-align:left" | '''Life GWP & Other Revenues''' |
|||
| style="text-align:right" | 34.5 |
|||
| style="text-align:right" | 37.5 |
|||
| style="text-align:right" | +9% |
|||
|- |
|- |
||
| style="text-align:left" | Protection |
| style="text-align:left" | Protection |
||
| Line 390: | Line 410: | ||
| style="text-align:right" | -7% |
| style="text-align:right" | -7% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Health GWP & Other Revenues''' |
||
| style="text-align:right |
| style="text-align:right" | 17.5 |
||
| style="text-align:right |
| style="text-align:right" | 19.0 |
||
| style="text-align:right |
| style="text-align:right" | +5% |
||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Health GWP & other revenues by line, FY24 vs FY25 <sup>p. 17</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | Individual |
| style="text-align:left" | Individual |
||
| Line 414: | Line 424: | ||
| style="text-align:right" | 7.9 |
| style="text-align:right" | 7.9 |
||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 17.5 |
|||
| style="text-align:right; font-weight:bold" | 19.0 |
|||
| style="text-align:right; font-weight:bold" | +5% |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 445: | Line 450: | ||
</div> |
</div> |
||
* Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24 |
|||
* '''Employee Benefits''' (including both short-term and long-term Employee Benefits GWP and other revenues) FY25: EUR 12.9bn (+4% vs. FY24) <sup>p. 17</sup> |
|||
* Employee Benefits (short-term and long-term) FY25: EUR 12.9bn (+4% vs. FY24) |
|||
* (bar) '''Net flows''': EUR +5.4bn vs. EUR +1.5bn in FY24 <sup>p. 17</sup> |
|||
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
||
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) <sup>p. 18</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 459: | Line 462: | ||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|||
| style="text-align:left" | '''PVEP''' |
|||
| style="text-align:right" | 50.9 |
|||
| style="text-align:right" | 49.4 |
|||
| style="text-align:right" | -2% |
|||
|- |
|- |
||
| style="text-align:left" | Protection & Health |
| style="text-align:left" | Protection & Health |
||
| Line 479: | Line 487: | ||
| style="text-align:right" | 1.7 |
| style="text-align:right" | 1.7 |
||
| style="text-align:right" | -10% |
| style="text-align:right" | -10% |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 50.9 |
|||
| style="text-align:right; font-weight:bold" | 49.4 |
|||
| style="text-align:right; font-weight:bold" | -2% |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ NB CSM |
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | NB CSM |
| style="text-align:left" | NB CSM (pre-tax) |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
| style="text-align:right" | +3% |
|||
|} |
|||
</div> |
|||
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ NBV (post-tax) and margin, FY24 vs FY25 <sup>p. 18</sup> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | NBV |
| style="text-align:left" | NBV (post-tax) |
||
| style="text-align:right" | 2.3 |
| style="text-align:right" | 2.3 |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
| Line 522: | Line 510: | ||
|} |
|} |
||
</div> |
</div> |
||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes |
|||
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits |
|||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France |
|||
* (bar) '''NB CSM''' (pre-tax) +3% (constant scope and FX) <sup>p. 18</sup> |
|||
=== Life & Health | Growth in new business driving Normalized CSM growth === |
=== Life & Health | Growth in new business driving Normalized CSM growth === |
||
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) <sup>p. 19</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual Service Margin rollforward |
|+ Contractual Service Margin rollforward <sup>p. 19</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Contractual Service Margin |
! class="col-s" style="text-align:right" | Contractual Service Margin |
||
| Line 559: | Line 550: | ||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
|||
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup> |
|||
{| class="wikitable fintable" |
|||
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup> |
|||
|+ CSM by segment, FY24 vs FY25 <sup>p. 19</sup> |
|||
! style="text-align:left" | EUR billion |
|||
* '''CSM o/w Life''': FY24 EUR 25.8bn, FY25 EUR 25.4bn <sup>p. 19</sup> |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
* '''CSM o/w Health''': FY24 EUR 7.7bn, FY25 EUR 7.6bn <sup>p. 19</sup> |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|||
| style="text-align:left" | Life |
|||
| style="text-align:right" | 25.8 |
|||
| style="text-align:right" | 25.4 |
|||
|- |
|||
| style="text-align:left" | Health |
|||
| style="text-align:right" | 7.7 |
|||
| style="text-align:right" | 7.6 |
|||
|} |
|||
</div> |
|||
* Normalized CSM up by +2% (constant scope and FX), with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates |
|||
* Economic variance reflecting government spreads tightening and positive equity market returns |
|||
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland |
|||
* FX impact mainly from JPY and HKD depreciation |
|||
=== Life & Health | Strong momentum in both short-term and long-term business === |
=== Life & Health | Strong momentum in both short-term and long-term business === |
||
| Line 569: | Line 576: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying |
|+ Underlying earnings walk, FY24 to FY25 <sup>p. 20</sup> |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | Underlying |
! class="col-s" style="text-align:right" | Underlying earnings |
||
|- |
|- |
||
| style="text-align:left" | FY24 |
| style="text-align:left" | FY24 |
||
| Line 593: | Line 600: | ||
</div> |
</div> |
||
* '''Underlying Earnings''' +7% ( |
* '''Underlying Earnings''' +7% (constant FX) <sup>p. 20</sup> |
||
* ''' |
* Strong '''short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup> |
||
* ''' |
* Higher '''long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup> |
||
* '''Underlying Earnings |
* '''Underlying Earnings by segment''': |
||
* ''' |
** '''Life''': FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) <sup>p. 20</sup> |
||
** '''Health''': FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) <sup>p. 20</sup> |
|||
* '''Short-term technical margin''': EUR 479m <sup>p. 20</sup> |
* '''Short-term technical margin''': EUR 479m <sup>p. 20</sup> |
||
* '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup> |
* '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup> |
||
| Line 607: | Line 615: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings and |
|+ Underlying earnings and net income by segment, FY24 vs FY25 <sup>p. 21</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 614: | Line 622: | ||
|- |
|- |
||
| style="text-align:left" | '''Underlying earnings''' |
| style="text-align:left" | '''Underlying earnings''' |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | +6% |
| style="text-align:right" | +6% |
||
|- |
|- |
||
| style="text-align:left" | Property & Casualty |
| style="text-align:left" | Property & Casualty |
||
| style="text-align:right" | |
| style="text-align:right" | 5.5 |
||
| style="text-align:right" | 5.9 |
| style="text-align:right" | 5.9 |
||
| style="text-align:right" | +9% |
| style="text-align:right" | +9% |
||
|- |
|- |
||
| style="text-align:left" | Life & Health |
| style="text-align:left" | Life & Health |
||
| style="text-align:right" | |
| style="text-align:right" | 3.3 |
||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
|- |
|- |
||
| style="text-align:left" | Asset Management |
| style="text-align:left" | Asset Management |
||
| style="text-align:right" | |
| style="text-align:right" | 0.4 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | -57% |
| style="text-align:right" | -57% |
||
|- |
|- |
||
| style="text-align:left" | Holdings & other |
| style="text-align:left" | Holdings & other |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | - |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Underlying earnings total |
||
| style="text-align:right" | |
| style="text-align:right" | 8.1 |
||
| style="text-align:right" | |
| style="text-align:right" | 8.4 |
||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | '''Net income''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | +26% |
| style="text-align:right" | +26% |
||
|- |
|- |
||
| style="text-align:left" | Non-financial flows |
| style="text-align:left" | Non-financial flows |
||
| style="text-align:right" | -0.5 |
| style="text-align:right" | -0.5 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.1 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal |
||
| style="text-align:right" | |
| style="text-align:right" | - |
||
| style="text-align:right" | |
| style="text-align:right" | 2.2 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Financial flows (incl. RCG) |
| style="text-align:left" | Financial flows (incl. RCG) |
||
| style="text-align:right" | |
| style="text-align:right" | 0.3 |
||
| style="text-align:right" | -0.7 |
| style="text-align:right" | -0.7 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Net income total |
|||
| style="text-align:right" | 7.9 |
|||
| style="text-align:right" | 9.8 |
|||
| style="text-align:right" | +26% |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 663: | Line 681: | ||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings per share walk, FY24 to FY25 <sup>p. 21</sup> |
|+ Underlying earnings per share walk, FY24 to FY25 <sup>p. 21</sup> |
||
! style="text-align:left" | EUR |
! style="text-align:left" | EUR |
||
! class="col-s" style="text-align:right" | Underlying earnings per share |
! class="col-s" style="text-align:right" | Underlying earnings per share |
||
|- |
|- |
||
| Line 683: | Line 701: | ||
</div> |
</div> |
||
* '''Underlying earnings''' |
* '''Underlying earnings''': Strong performance from insurance businesses <sup>p. 21</sup> |
||
* ''' |
* '''Underlying earnings''': Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup> |
||
* '''Net income''' mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup> |
* '''Net income''': Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup> |
||
* ''' |
* '''Net income''': Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup> |
||
* |
* Change at constant FX for underlying earnings and net income <sup>p. 21</sup> |
||
* |
* Change on reported basis for underlying earnings per share <sup>p. 21</sup> |
||
* (bar) '''Underlying earnings per share''': EUR 3.59 (FY24) → EUR 3.86 (FY25) (+8%) <sup>p. 21</sup> |
|||
* including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback <sup>p. 21</sup> |
|||
=== Shareholders' Equity === |
=== Shareholders' Equity === |
||
| Line 729: | Line 749: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Shareholders' equity |
|+ Shareholders' equity reconciliation, FY24 to FY25 and HY25 to FY25 <sup>p. 22</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 to FY25 |
! class="col-s" style="text-align:right" | FY24 to FY25 |
||
| Line 748: | Line 768: | ||
| style="text-align:left" | Dividend |
| style="text-align:left" | Dividend |
||
| style="text-align:right" | -4.6 |
| style="text-align:right" | -4.6 |
||
| style="text-align:right" | |
| style="text-align:right" | - |
||
|- |
|- |
||
| style="text-align:left" | Annual share buyback |
| style="text-align:left" | Annual share buyback |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | - |
||
|- |
|- |
||
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM |
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM |
||
| Line 775: | Line 795: | ||
|} |
|} |
||
</div> |
</div> |
||
* 1. Shareholders' equity Group share <sup>p. 22</sup> |
|||
* '''Shareholders' equity reconciliation''' (in Euro billion) <sup>p. 22</sup> |
|||
=== Higher organic cash remittance and robust cash position at Holding === |
=== Higher organic cash remittance and robust cash position at Holding === |
||
| Line 780: | Line 803: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Cash |
|+ Net Cash Remittance and Cash Position, FY24 vs FY25 <sup>p. 23</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | Net Cash Remittance |
| style="text-align:left" | Net Cash Remittance |
||
| style="text-align:right" | 7.7 |
| style="text-align:right" | 7.7 |
||
| style="text-align:right" | 7.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Remittance ratio |
||
| style="text-align:right" | |
| style="text-align:right" | 82% |
||
|- |
|||
| style="text-align:left" | Proceeds related to in-force treaties² (FY24) |
|||
| style="text-align:right" | 0.6 |
|||
|- |
|||
| style="text-align:left" | Remittance ratio¹ (FY24) |
|||
| style="text-align:right" | 82% |
| style="text-align:right" | 82% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Cash position |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | 4.0 |
||
|- |
|||
| style="text-align:left" | Net cash remittance from subsidiaries |
|||
| style="text-align:right" | +7.5 |
|||
|- |
|||
| style="text-align:left" | Dividend |
|||
| style="text-align:right" | -4.6 |
|||
|- |
|||
| style="text-align:left" | Annual share buyback |
|||
| style="text-align:right" | -1.2 |
|||
|- |
|||
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM |
|||
| style="text-align:right" | -3.5 |
|||
|- |
|||
| style="text-align:left" | Holding costs and interest expenses |
|||
| style="text-align:right" | -1.3 |
|||
|- |
|||
| style="text-align:left" | Change in net debt |
|||
| style="text-align:right" | +1.6 |
|||
|- |
|||
| style="text-align:left" | M&A and other |
|||
| style="text-align:right" | +3.1 |
|||
|- |
|||
| style="text-align:left" | FY25 Cash position |
|||
| style="text-align:right" | 5.6 |
| style="text-align:right" | 5.6 |
||
|- |
|||
| style="text-align:left" | Net Cash Remittance (FY25) |
|||
| style="text-align:right" | 7.5 |
|||
|- |
|||
| style="text-align:left" | Remittance ratio¹ (FY25) |
|||
| style="text-align:right" | 82% |
|||
|} |
|} |
||
</div> |
</div> |
||
* |
* FY24 Net Cash Remittance includes EUR 7.1bn (base) and EUR 0.6bn Proceeds related to in-force treaties². |
||
* Net cash remittance from subsidiaries: +EUR 7.5bn |
|||
* ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>. |
|||
* Dividend: -EUR 4.6bn |
|||
* Annual share buyback: -EUR 1.2bn |
|||
* Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn |
|||
* Holding costs and interest expenses: -EUR 1.3bn |
|||
* Change in net debt: +EUR 1.6bn |
|||
* M&A and other: +EUR 3.1bn |
|||
* 1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25 |
|||
* 2. EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe |
|||
=== Solvency II at 224% === |
=== Solvency II at 224% === |
||
| Line 838: | Line 837: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II walk |
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | EOF |
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF) |
||
! class="col-s" style="text-align:right" | SCR |
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR) |
||
! class="col-s" style="text-align:right" | Solvency II ratio (pts) |
! class="col-s" style="text-align:right" | Solvency II ratio (pts) |
||
|- |
|- |
||
| Line 888: | Line 887: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Key sensitivities on Solvency II |
|+ Key sensitivities on Solvency II ratio as of December 31, 2025 (224%) <sup>p. 24</sup> |
||
! style="text-align:left" | Sensitivity |
! style="text-align:left" | Sensitivity |
||
! class="col-s" style="text-align:right" | Impact (pts) |
! class="col-s" style="text-align:right" | Impact (pts) |
||
| Line 924: | Line 923: | ||
</div> |
</div> |
||
* Dividend & annual share buyback: Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn |
|||
* ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>. |
|||
* |
* 1. Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) |
||
* 2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) |
|||
* Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup> |
|||
=== Solvency II -impact of the end of grandfathering period and Solvency II revision === |
=== Solvency II -impact of the end of grandfathering period and Solvency II revision === |
||
| Line 932: | Line 931: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II ratio |
|+ Solvency II ratio outlook <sup>p. 25</sup> |
||
! style="text-align:left" | Item |
! style="text-align:left" | Item |
||
! class="col- |
! class="col-m" style="text-align:right" | Value |
||
|- |
|- |
||
| style="text-align:left" | Ratio as of 31/12/2025 |
| style="text-align:left" | Ratio as of 31/12/2025 |
||
| style="text-align:right" | 224 |
| style="text-align:right" | 224% |
||
|- |
|- |
||
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
||
| style="text-align:right" | - |
| style="text-align:right" | -10pts to 215% |
||
|- |
|||
| style="text-align:left" | Ratio after grandfathering impact |
|||
| style="text-align:right" | 215 |
|||
|- |
|- |
||
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
||
| style="text-align:right" | + |
| style="text-align:right" | +17pts |
||
|} |
|} |
||
</div> |
</div> |
||
* |
* Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
||
* No change expected in organic capital generation |
* No change expected in organic capital generation |
||
* Additional capital flexibility |
* Additional capital flexibility |
||
* |
* 1. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date |
||
=== Thomas Buberl, Group CEO conclusion === |
=== Thomas Buberl, Group CEO conclusion === |
||
* Conclusion |
* Conclusion <sup>p. 26</sup> |
||
* Thomas Buberl, Group CEO <sup>p. 26</sup> |
|||
=== Conclusion === |
=== Conclusion === |
||
| Line 968: | Line 965: | ||
=== February 26, 2026 Q&A Full Year 2025 earnings === |
=== February 26, 2026 Q&A Full Year 2025 earnings === |
||
* Q&A |
* Q&A <sup>p. 28</sup> |
||
* |
* Full Year 2025 Earnings <sup>p. 28</sup> |
||
* February 26, 2026 <sup>p. 28</sup> |
|||
=== AXA Investor Relations | Keep in touch === |
=== AXA Investor Relations | Keep in touch === |
||
* ''' |
* '''Contact us''': <sup>p. 29</sup> |
||
** Investor Relations +33 1 40 75 48 42 <sup>p. 29</sup> |
|||
** investor.relations@axa.com <sup>p. 29</sup> |
|||
* '''Follow us''': www.axa.com <sup>p. 29</sup> |
|||
* '''Upcoming events''': <sup>p. 29</sup> |
|||
** March: Roadshows in Europe and US <sup>p. 29</sup> |
** March: Roadshows in Europe and US <sup>p. 29</sup> |
||
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup> |
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup> |
||
| Line 980: | Line 982: | ||
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup> |
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup> |
||
** September 21: AXA Investor Day in London <sup>p. 29</sup> |
** September 21: AXA Investor Day in London <sup>p. 29</sup> |
||
* '''Contact us''' <sup>p. 29</sup> |
|||
** Investor Relations: +33 1 40 75 48 42 <sup>p. 29</sup> |
|||
** Email: investor.relations@axa.com <sup>p. 29</sup> |
|||
* '''Follow us''' <sup>p. 29</sup> |
|||
** Website: www.axa.com <sup>p. 29</sup> |
|||
** Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon <sup>p. 29</sup> |
|||
== Appendices == |
== Appendices == |
||
| Line 991: | Line 987: | ||
* Appendices <sup>p. 30</sup> |
* Appendices <sup>p. 30</sup> |
||
* '''Debt and Invested Assets''' p.31 |
* '''Debt and Invested Assets''' <sup>p. 31</sup> |
||
* Additional P&C disclosures p.36 |
* Additional P&C disclosures <sup>p. 36</sup> |
||
* Additional IFRS17 disclosures p.41 |
* Additional IFRS17 disclosures <sup>p. 41</sup> |
||
* Sustainability p.44 |
* Sustainability <sup>p. 44</sup> |
||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
||
| Line 1,000: | Line 996: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Gross financial debt by type |
|+ Gross financial debt by type <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 2 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Senior debt |
||
! class="col-s" style="text-align:right" | Total |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY24 |
||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 4.8 |
|||
| style="text-align:right" | 19.2 |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | 12.2 |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 22.3 |
|||
|- |
|||
| style="text-align:left" | Jan 1st 2026 |
|||
| style="text-align:right" | 5.8 |
| style="text-align:right" | 5.8 |
||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 12.2 |
|||
| style="text-align:right" | 11.3 |
| style="text-align:right" | 11.3 |
||
|- |
|||
| style="text-align:left" | Senior debt |
|||
| style="text-align:right" | 4.8 |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 3.2 |
| style="text-align:right" | 3.2 |
||
| style="text-align:right" | 20.3 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 19.2 |
|||
| style="text-align:right; font-weight:bold" | 22.3 |
|||
| style="text-align:right; font-weight:bold" | 20.3 |
|||
|} |
|} |
||
</div> |
</div> |
||
Debt gearing: 20.6% for FY24; 22.3% for FY25 <sup>p. 32</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual maturity breakdown |
|+ Contractual maturity breakdown <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Senior debt |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 2 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | 2026 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | 2027 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | 2028 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 4.6 |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
|- |
|||
| style="text-align:left" | 2029 |
|||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
|- |
|||
| style="text-align:left" | 2030 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | 2031-2039 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | 1.4 |
|||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Grandfathered debt |
|+ Grandfathered debt contractual maturity <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 2 |
||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2031-2039 |
||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | ≥2040 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Economic maturity breakdown |
|+ Economic maturity breakdown <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Senior debt |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 2 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 2.4 |
|||
| style="text-align:right" | 2.0 |
|||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 4.0 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2026 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|||
| style="text-align:left" | 2027 |
|||
| style="text-align:right" | 2.4 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align: |
| style="text-align:left" | 2028 |
||
| style="text-align:right" | 2.0 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2029 |
||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|||
| style="text-align:left" | 2030 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|||
| style="text-align:left" | 2031-2039 |
|||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | 1.5 |
|||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0.7 |
|||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 4.0 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 1.5 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Grandfathered debt |
|+ Grandfathered debt economic maturity <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Tier 2 |
||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2031-2039 |
||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | 0.8 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | ≥2040 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 0.8 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
Nominal debt <sup>p. 32</sup> |
|||
* Debt gearing: FY24 20.6%; FY25 22.3% <sup>p. 32</sup> |
|||
In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup> |
|||
* In January 2026, AXA called the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 <sup>p. 32</sup> |
|||
* In January 2026, AXA called the T1 GF €250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup> |
|||
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup> |
|||
This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable <sup>p. 32</sup> |
|||
* For Solvency 2 RT1 debt, the undated nature of the instrument is retained for this diagram, as it has no step-up <sup>p. 32</sup> |
|||
Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time <sup>p. 32</sup> |
|||
* '''Jan 1st 2026''' (End of the grandfathering period): Total |
* '''Jan 1st 2026''' (End of the grandfathering period): Total 20.3; Tier 1 5.8 (o/w EUR 0.4bn redeemed in Jan 2026); Tier 2 11.3; Senior debt 3.2 <sup>p. 32</sup> |
||
=== General Account invested assets === |
=== General Account invested assets === |
||
| Line 1,174: | Line 1,186: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ FY25 Total General Account invested assets |
|+ FY25 Total General Account invested assets <sup>p. 33</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | Share |
|||
|- |
|||
| style="text-align:left" | Fixed income |
|||
| style="text-align:right" | 77% |
|||
|- |
|||
| style="text-align:left" | Real estate |
|||
| style="text-align:right" | 9% |
|||
|- |
|||
| style="text-align:left" | Infrastructure equity |
|||
| style="text-align:right" | 2% |
|||
|- |
|||
| style="text-align:left" | Listed equities |
|||
| style="text-align:right" | 2% |
|||
|- |
|||
| style="text-align:left" | Private equity and hedge funds |
|||
| style="text-align:right" | 5% |
|||
|- |
|||
| style="text-align:left" | Cash |
|||
| style="text-align:right" | 4% |
|||
|- |
|||
| style="text-align:left" | Policy loans |
|||
| style="text-align:right" | 0% |
|||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Invested assets by type, FY25 <sup>p. 33</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Value |
|||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
|- |
|- |
||
| Line 1,210: | Line 1,193: | ||
| style="text-align:right" | 345 |
| style="text-align:right" | 345 |
||
| style="text-align:right" | 77% |
| style="text-align:right" | 77% |
||
|- |
|||
| style="text-align:left; padding-left:1.5em" | o/w Government bonds |
|||
| style="text-align:right" | 167 |
|||
| style="text-align:right" | 37% |
|||
|- |
|||
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans |
|||
| style="text-align:right" | 121 |
|||
| style="text-align:right" | 27% |
|||
|- |
|||
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income |
|||
| style="text-align:right" | 56 |
|||
| style="text-align:right" | 13% |
|||
|- |
|- |
||
| style="text-align:left" | Real estate |
| style="text-align:left" | Real estate |
||
| Line 1,247: | Line 1,218: | ||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total Insurance Invested Assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''450''' |
||
| style="text-align:right |
| style="text-align:right" | '''100%''' |
||
|} |
|} |
||
</div> |
</div> |
||
Duration gap: -0.4 year <sup>p. 33</sup> |
|||
* Duration gap: -0.4 year <sup>p. 33</sup> |
|||
¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup> |
|||
* o/w Government bonds: 167 (37%) <sup>p. 33</sup> |
|||
* o/w Corporate bonds and loans: 121 (27%) <sup>p. 33</sup> |
|||
³ '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup> |
|||
* o/w Other fixed income: 56 (13%) <sup>p. 33</sup> |
|||
** Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup> |
|||
* Listed equities includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup> |
|||
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup> |
|||
* Refer to the financial supplement for more details <sup>p. 33</sup> |
|||
=== Structured and Private Credit assets === |
=== Structured and Private Credit assets === |
||
| Line 1,262: | Line 1,237: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Invested assets by type, FY25 <sup>p. 34</sup> |
|+ Invested assets by structured and private credit type, FY25 <sup>p. 34</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | % of total G/A portfolio |
||
! class="col-s" style="text-align:right" | Share of G/A portfolio |
|||
|- |
|- |
||
| style="text-align:left" | Residential Mortgages |
| style="text-align:left" | Residential Mortgages |
||
| Line 1,291: | Line 1,265: | ||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total Structured and Private Credit Assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''69''' |
||
| style="text-align:right |
| style="text-align:right" | '''15%''' |
||
|} |
|} |
||
</div> |
</div> |
||
G/A: General Account <sup>p. 34</sup> |
|||
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 34</sup> |
|||
* '''Invested assets''' (100%) in EUR bn (FY25): |
|||
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup> |
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup> |
||
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and |
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 93% rated AAA-AA) <sup>p. 34</sup> |
||
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup> |
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup> |
||
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup> |
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup> |
||
* Strong diversification with EUR 8m average ticket <sup>p. 34</sup> |
|||
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup> |
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup> |
||
* o/w 54% participating <sup>p. 34</sup> |
* o/w 54% participating <sup>p. 34</sup> |
||
* G/A: General Account <sup>p. 34</sup> |
|||
=== Investment portfolio | Fixed Income reinvestment === |
=== Investment portfolio | Fixed Income reinvestment === |
||
| Line 1,309: | Line 1,285: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ FY25 Fixed Income Reinvestment |
|+ FY25 Fixed Income Reinvestment <sup>p. 35</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | Value |
|||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
! class="col-s" style="text-align:right" | Average rating |
|||
! class="col-s" style="text-align:right" | Yield |
! class="col-s" style="text-align:right" | Yield |
||
|- |
|- |
||
| style="text-align:left" | Government bonds & related |
| style="text-align:left" | Government bonds & related |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 32% |
| style="text-align:right" | 32% |
||
| style="text-align:right" | AA |
|||
| style="text-align:right" | 3.5% |
| style="text-align:right" | 3.5% |
||
|- |
|- |
||
| style="text-align:left" | Investment grade credit |
| style="text-align:left" | Investment grade credit |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 40% |
| style="text-align:right" | 40% |
||
| style="text-align:right" | A |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | ABS/CLO/IG fund financing |
| style="text-align:left" | ABS/CLO/IG fund financing |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 21% |
| style="text-align:right" | 21% |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Below investment grade credit |
| style="text-align:left" | Below investment grade credit |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7% |
| style="text-align:right" | 7% |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Public fixed income |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3.5% |
|||
|- |
|- |
||
| style="text-align:left" | Private & Structured fixed income |
| style="text-align:left" | Private & Structured fixed income |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 4.7% |
| style="text-align:right" | 4.7% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed income''' |
||
| style="text-align:right |
| style="text-align:right" | — |
||
| style="text-align:right |
| style="text-align:right" | — |
||
| style="text-align:right |
| style="text-align:right" | '''3.9%''' |
||
|} |
|} |
||
</div> |
</div> |
||
* Euro 57 billion fixed income invested at 3.9% |
|||
* EUR 57 billion fixed income invested at 3.9% <sup>p. 35</sup> |
|||
** Average duration of 9 years |
|||
** Average duration of 9 years <sup>p. 35</sup> |
|||
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) |
|||
** Includes EUR 19.7 billion of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup> |
|||
** Gradual shift from alternative total return assets to Private & Structured credit |
|||
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup> |
|||
* ¹ '''Government bonds & related''' refers to Government and Corporate bonds and related |
|||
* Government and Corporate bonds and related <sup>p. 35</sup> |
|||
* ² '''Private & Structured fixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) |
|||
* Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup> |
|||
* '''Table of contents''': |
* '''Table of contents''': |
||
| Line 1,363: | Line 1,345: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ FY25 GWP by line of business and geography <sup>p. 37</sup> |
|+ FY25 GWP by line of business and geography, USD 19bn total <sup>p. 37</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Line of business share |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Geography share |
||
|- |
|- |
||
| style="text-align:left" | Casualty |
| style="text-align:left" | Casualty |
||
| Line 1,395: | Line 1,377: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 19% |
| style="text-align:right" | 19% |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 19 |
|||
| style="text-align:right; font-weight:bold" | 19 |
|||
|} |
|} |
||
</div> |
</div> |
||
* Well diversified across lines of business and geographies |
* Well diversified across lines of business and geographies <sup>p. 37</sup> |
||
* Leading market positions across lines |
* Leading market positions across lines <sup>p. 37</sup> |
||
** Top 3 globally |
** Top 3 globally <sup>p. 37</sup> |
||
** Multinational Programs <sup>p. 37</sup> |
|||
** Marine <sup>p. 37</sup> |
|||
*** Marine (Source: Aon, Guy Carpenter, and Global Market Insights) |
|||
** Fine Art & Specie <sup>p. 37</sup> |
|||
* Managing the cycle to deliver consistent profitability |
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup> |
||
** (scatter plot) '''Profitability vs. Ex-price growth''': |
** (scatter plot) '''Profitability vs. Ex-price growth (%)''': |
||
*** Property ( |
*** Property (high profitability, high ex-price growth) <sup>p. 37</sup> |
||
*** Specialty ( |
*** Specialty (medium profitability, medium ex-price growth) <sup>p. 37</sup> |
||
*** Casualty ( |
*** Casualty (medium profitability, low ex-price growth) <sup>p. 37</sup> |
||
*** Professional lines ( |
*** Professional lines (low profitability, low ex-price growth) <sup>p. 37</sup> |
||
=== P&C | Focus on Reserves === |
=== P&C | Focus on Reserves === |
||
| Line 1,418: | Line 1,396: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Claims and technical reserves ratios |
|+ Claims and technical reserves ratios, FY18-FY25 <sup>p. 38</sup> |
||
! style="text-align:left" | % |
! style="text-align:left" | % |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS4) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS17) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS4) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS17) |
||
! class="col-s" style="text-align:right" | FY22 |
|||
! class="col-s" style="text-align:right" | FY23 |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY18 |
||
| style="text-align:right" | 179 |
| style="text-align:right" | 179% |
||
| style="text-align:right" | 185 |
|||
| style="text-align:right" | 193 |
|||
| style="text-align:right" | 188 |
|||
| style="text-align:right" | 189 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 213% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY19 |
||
| style="text-align:right" | 185% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | FY20 |
|||
| style="text-align:right" | 193% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 233% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 198 |
|||
| style="text-align:right" | 195 |
|||
| style="text-align:right" | 180 |
|||
| style="text-align:right" | 175 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY21 |
||
| style="text-align:right" | |
| style="text-align:right" | 188% |
||
| style="text-align:right" | 227 |
|||
| style="text-align:right" | 233 |
|||
| style="text-align:right" | 226 |
|||
| style="text-align:right" | 227 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 226% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | FY22 |
|||
| style="text-align:right" | 189% |
|||
| style="text-align:right" | 198% |
|||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | 234% |
|||
|- |
|||
| style="text-align:left" | FY23 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 195% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 232% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY24 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 180% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 216% |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 175% |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 210% |
||
| style="text-align:right" | 232 |
|||
| style="text-align:right" | 216 |
|||
| style="text-align:right" | 210 |
|||
|} |
|} |
||
</div> |
</div> |
||
* Technical reserves include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup> |
|||
* '''Claims reserves ratio''' (Net undiscounted claims reserves/Net earned premiums) <sup>p. 38</sup> |
* '''Claims reserves ratio''' (Net undiscounted claims reserves/Net earned premiums) <sup>p. 38</sup> |
||
* '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup> |
* '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup> |
||
| Line 1,479: | Line 1,459: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Insurance segment occurrence protection |
|+ Insurance segment occurrence protection, 2026 <sup>p. 39</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Capacity |
! class="col-s" style="text-align:right" | Capacity |
||
| Line 1,486: | Line 1,466: | ||
| style="text-align:left" | EU Windstorm |
| style="text-align:left" | EU Windstorm |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | 4.0 |
||
| style="text-align:right" | |
| style="text-align:right" | 600m |
||
|- |
|- |
||
| style="text-align:left" | Europe Flood |
| style="text-align:left" | Europe Flood |
||
| style="text-align:right" | 2.1 |
| style="text-align:right" | 2.1 |
||
| style="text-align:right" | |
| style="text-align:right" | 450m |
||
|- |
|- |
||
| style="text-align:left" | Europe Earthquake |
| style="text-align:left" | Europe Earthquake |
||
| style="text-align:right" | 2.1 |
| style="text-align:right" | 2.1 |
||
| style="text-align:right" | |
| style="text-align:right" | 400m |
||
|- |
|- |
||
| style="text-align:left" | NA Hurricane |
| style="text-align:left" | NA Hurricane |
||
| style="text-align:right" | 1.2 |
| style="text-align:right" | 1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | 600m |
||
|- |
|- |
||
| style="text-align:left" | NA Earthquake |
| style="text-align:left" | NA Earthquake |
||
| style="text-align:right" | 1.2 |
| style="text-align:right" | 1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | 600m |
||
|- |
|- |
||
| style="text-align:left" | Per other perils |
| style="text-align:left" | Per other perils |
||
| style="text-align:right" | |
| style="text-align:right" | 1.0 |
||
| style="text-align:right" | |
| style="text-align:right" | 400m |
||
|} |
|} |
||
</div> |
</div> |
||
* Stable retention levels maintained in 2026 as in 2025 |
* Stable retention levels maintained in 2026 as in 2025 |
||
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds |
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds |
||
* Excludes local reinsurance covers |
* Footnote 1: Excludes local reinsurance covers |
||
* Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) |
* Footnote 2: Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) |
||
* Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils |
* Footnote 3: Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type. |
||
* Capacity varies by peril type <sup>p. 39</sup> |
|||
* '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup> |
|||
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| class="wikitable" |
||
|+ Group underlying earnings deviation to average Nat Cat charges |
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Percentile |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Deviation |
||
! class="col-m" style="text-align:right" | Average Expected Nat Cat charges |
|||
|- |
|- |
||
| style="text-align:left" | 1/20y (95th percentile) |
| style="text-align:left" | 1/20y (95th percentile) |
||
| style="text-align:right" | -1. |
| class="col-s" style="text-align:right" | -EUR 1.2bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 1/10y (90th percentile) |
| style="text-align:left" | 1/10y (90th percentile) |
||
| style="text-align:right" | -0. |
| class="col-s" style="text-align:right" | -EUR 0.8bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 1/5y (80th percentile) |
| style="text-align:left" | 1/5y (80th percentile) |
||
| style="text-align:right" | -0. |
| class="col-s" style="text-align:right" | -EUR 0.4bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Median (50th percentile) |
| style="text-align:left" | Median (50th percentile) |
||
| style="text-align:right" | 0. |
| class="col-s" style="text-align:right" | EUR 0.1bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 1/5y (20th percentile) |
| style="text-align:left" | 1/5y (20th percentile) |
||
| style="text-align:right" | 0. |
| class="col-s" style="text-align:right" | EUR 0.5bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 1/10y (10th percentile) |
| style="text-align:left" | 1/10y (10th percentile) |
||
| style="text-align:right" | 0. |
| class="col-s" style="text-align:right" | EUR 0.7bn |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 1/20y (5th percentile) |
| style="text-align:left" | 1/20y (5th percentile) |
||
| style="text-align:right" | 0. |
| class="col-s" style="text-align:right" | EUR 0.8bn |
||
|} |
|||
| style="text-align:right" | — |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Average Expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
! class="col-s" style="text-align:right" | 2026 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Average Expected Nat Cat charges |
||
| style="text-align:right" | |
| style="text-align:right" | 2.6 |
||
| style="text-align:right" | 2. |
| style="text-align:right" | 2.7 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Estimated impact on GEP |
||
| style="text-align:right" | |
| style="text-align:right" | 4.5% |
||
| style="text-align:right" | |
| style="text-align:right" | 4.5% |
||
|} |
|} |
||
</div> |
</div> |
||
* Footnote 1: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). |
|||
* '''More severe years - Negative deviation in ca. 40% of cases''' <sup>p. 40</sup> |
|||
* ''' |
* (bar) '''More severe years (Negative deviation in ca. 40% of cases)''': |
||
* (bar) '''Less severe years (Positive deviation in ca. 60% of cases)''': |
|||
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup> |
|||
* Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup> |
|||
* '''Average Expected Nat Cat charges''' net of reinsurance, pre-tax (in Euro billion) <sup>p. 40</sup> |
|||
* |
* '''Table of contents''' <sup>p. 41</sup> |
||
* |
** 1. Debt and Invested Assets <sup>p. 31</sup> |
||
* |
** 2. Additional P&C disclosures <sup>p. 36</sup> |
||
* |
** 3. Additional IFRS17 disclosures <sup>p. 41</sup> |
||
** 4. Sustainability <sup>p. 44</sup> |
|||
=== P&C | Margin analysis === |
=== P&C | Margin analysis === |
||
| Line 1,580: | Line 1,558: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ P&C Underlying Earnings walk, |
|+ P&C Underlying Earnings walk, FY24 to FY25 <sup>p. 42</sup> |
||
! style="text-align:left" | EUR million unless otherwise mentioned |
! style="text-align:left" | EUR million unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| Line 1,632: | Line 1,610: | ||
| style="text-align:right" | -1.1% |
| style="text-align:right" | -1.1% |
||
| style="text-align:right" | +0.7pt |
| style="text-align:right" | +0.7pt |
||
|- |
|||
| style="text-align:left" | Sensitivity to Current Accident Year discount rate changes +25bps |
|||
| style="text-align:right" | +0.2bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Sensitivity to Current Accident Year discount rate changes -25bps |
|||
| style="text-align:right" | -0.2bn |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | '''Financial Result''' |
| style="text-align:left" | '''Financial Result''' |
||
| Line 1,675: | Line 1,645: | ||
| style="text-align:left" | 2025 Insurance Finance Expenses (pre-tax) |
| style="text-align:left" | 2025 Insurance Finance Expenses (pre-tax) |
||
| style="text-align:right" | ~-1.4bn |
| style="text-align:right" | ~-1.4bn |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount +25bps |
|||
| style="text-align:right" | ~-50m |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount -25bps |
|||
| style="text-align:right" | ~+50m |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| Line 1,700: | Line 1,662: | ||
| style="text-align:right" | 5,872 |
| style="text-align:right" | 5,872 |
||
| style="text-align:right" | +501 |
| style="text-align:right" | +501 |
||
|- |
|||
| style="text-align:left" | Growth vs. FY24 (at constant FX) |
|||
| style="text-align:right" | +9% |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
|||
* Growth vs. FY24 (at constant FX): +9% |
|||
{| class="wikitable fintable" |
|||
* (flow) '''Technical Result''' (in EUR million, pre-tax) <sup>p. 42</sup> |
|||
|+ Sensitivity to Current Accident Year discount rate changes <sup>p. 42</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Impact |
|||
|- |
|||
| style="text-align:left" | +25bps |
|||
| style="text-align:right" | +0.2 |
|||
|- |
|||
| style="text-align:left" | -25bps |
|||
| style="text-align:right" | -0.2 |
|||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
|+ Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup> |
|||
! style="text-align:left" | EUR million |
|||
! class="col-s" style="text-align:right" | Impact |
|||
|- |
|||
| style="text-align:left" | +25bps |
|||
| class="col-s" style="text-align:right" | ~-50 |
|||
|- |
|||
| style="text-align:left" | -25bps |
|||
| class="col-s" style="text-align:right" | ~+50 |
|||
|} |
|||
</div> |
|||
* Changes versus FY24 at constant FX <sup>p. 42</sup> |
|||
* Reinvestment yield on fixed income assets <sup>p. 42</sup> |
|||
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve <sup>p. 42</sup> |
|||
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 42</sup> |
|||
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 42</sup> |
|||
* (flow) '''Underlying Earnings before tax''' <sup>p. 42</sup> |
|||
=== L&H | Margin analysis === |
=== L&H | Margin analysis === |
||
| Line 1,711: | Line 1,708: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ L&H Underlying Earnings walk, |
|+ L&H Underlying Earnings walk, FY24 to FY25 <sup>p. 43</sup> |
||
! style="text-align:left" | EUR million unless otherwise mentioned |
! style="text-align:left" | EUR million unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| Line 1,791: | Line 1,788: | ||
| style="text-align:right" | 3,501 |
| style="text-align:right" | 3,501 |
||
| style="text-align:right" | +219 |
| style="text-align:right" | +219 |
||
|- |
|||
| style="text-align:left" | Growth vs. FY24 (at constant FX) |
|||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
* Includes scope impact |
|||
* Growth vs. FY24 (at constant FX): +7% |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,834: | Line 1,832: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Invested assets |
|+ Invested assets <sup>p. 43</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Value |
|||
! class="col-s" style="text-align:right" | % of total G/A portfolio |
! class="col-s" style="text-align:right" | % of total G/A portfolio |
||
|- |
|- |
||
| Line 1,862: | Line 1,861: | ||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total Structured and Private Credit Assets''' |
||
| style="text-align:right |
| style="text-align:right" | 69 |
||
| style="text-align:right |
| style="text-align:right" | 15% |
||
|} |
|} |
||
</div> |
</div> |
||
* Includes scope impact <sup>p. 43</sup> |
|||
* EUR 6bn Dutch mortgages, NHG guaranteed |
|||
* Changes versus FY24 at constant FX <sup>p. 43</sup> |
|||
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
|||
* Reinvestment yield on fixed income assets <sup>p. 43</sup> |
|||
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
|||
* Incl. recapture of Laya <sup>p. 43</sup> |
|||
* Skewed towards resilient industries (Telecom, Utilities, Transport) |
|||
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup> |
|||
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
|||
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup> |
|||
* Strong diversification with EUR 8m average ticket |
|||
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup> |
|||
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation |
|||
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup> |
|||
* o/w 54% participating |
|||
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup> |
|||
* (flow) '''Technical Result''' (in EUR million, pre-tax) <sup>p. 43</sup> |
|||
* |
* Strong diversification with EUR 8m average ticket <sup>p. 43</sup> |
||
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup> |
|||
* o/w 54% participating <sup>p. 43</sup> |
|||
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
|||
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
|||
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup> |
|||
* '''Table of contents''' <sup>p. 44</sup> |
|||
** 1. Debt and Invested Assets <sup>p. 31</sup> |
|||
** 2. Additional P&C disclosures <sup>p. 36</sup> |
|||
** 3. Additional IFRS17 disclosures <sup>p. 41</sup> |
|||
** 4. Sustainability <sup>p. 44</sup> |
|||
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
||
| Line 1,883: | Line 1,893: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ Sustainability |
|+ AXA's Sustainability Targets and 2025 Results <sup>p. 45</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | — |
||
! class="col-m" style="text-align:right" | Target |
! class="col-m" style="text-align:right" | Target |
||
! class="col-m" style="text-align:right" | 2025 Result |
! class="col-m" style="text-align:right" | 2025 Result |
||
|- |
|- |
||
| style="text-align:left" | As a Global INVESTOR |
| style="text-align:left" | '''As a Global INVESTOR''' |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | — |
||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Climate transition financing |
|||
| class="col-m" style="text-align:right" | EUR 5bn per year |
|||
| class="col-m" style="text-align:right" | EUR 6.4bn |
| class="col-m" style="text-align:right" | EUR 6.4bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Community resilience financing |
||
| class="col-m" style="text-align:right" | EUR 500m |
| class="col-m" style="text-align:right" | EUR 500m per year |
||
| class="col-m" style="text-align:right" | EUR 1.4bn |
| class="col-m" style="text-align:right" | EUR 1.4bn |
||
|- |
|- |
||
| style="text-align:left" | As a Global INSURER |
| style="text-align:left" | '''As a Global INSURER''' |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | — |
||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | P&C GWP to support transition underwriting (cumulative 2024-2026) |
|||
| class="col-m" style="text-align:right" | EUR 6bn |
|||
| class="col-m" style="text-align:right" | EUR 4.6bn |
| class="col-m" style="text-align:right" | EUR 4.6bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026) |
||
| class="col-m" style="text-align:right" | >20,000 |
| class="col-m" style="text-align:right" | >20,000 |
||
| class="col-m" style="text-align:right" | 19,698 Cumulative 2024-2025 |
| class="col-m" style="text-align:right" | 19,698 Cumulative 2024-2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Inclusive insurance customers by 2026 |
||
| class="col-m" style="text-align:right" | >20m |
| class="col-m" style="text-align:right" | >20m |
||
| class="col-m" style="text-align:right" | 20.6m |
| class="col-m" style="text-align:right" | 20.6m |
||
|- |
|- |
||
| style="text-align:left" | As a COMPANY |
| style="text-align:left" | '''As a COMPANY''' |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | — |
||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | AXA Group employees trained on climate adaptation by 2026 |
|||
| class="col-m" style="text-align:right" | >80,000 |
|||
| class="col-m" style="text-align:right" | 46,420 |
| class="col-m" style="text-align:right" | 46,420 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Contribute to Net-Zero in absolute carbon emissions by 2030 |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | -50% by 2030 |
||
| class="col-m" style="text-align:right" | -64% Reduction against 2019 |
| class="col-m" style="text-align:right" | -64% Reduction against 2019 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Percentage of AXA Group employees engaged in volunteering activities by 2026 |
||
| class="col-m" style="text-align:right" | 50% |
| class="col-m" style="text-align:right" | 50% |
||
| class="col-m" style="text-align:right" | 56% |
| class="col-m" style="text-align:right" | 56% |
||
|} |
|} |
||
</div> |
</div> |
||
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup> |
|||
* Scope: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 <sup>p. 45</sup> |
|||
* Scope: AXA France, AXA Germany, AXA Switzerland, AXA XL, AXA Hong Kong, AXA Japan, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 <sup>p. 45</sup> |
|||
* Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include: (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in the target for the 2024-2026 period, from >9,000 to >20,000 <sup>p. 45</sup> |
|||
* Inclusive insurance includes underserved populations and markets and modest income segments in mature markets <sup>p. 45</sup> |
|||
* Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 <sup>p. 45</sup> |
|||
* Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 <sup>p. 45</sup> |
|||
* Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) <sup>p. 45</sup> |
|||
* Target revised in 2025 <sup>p. 45</sup> |
* Target revised in 2025 <sup>p. 45</sup> |
||
* Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. <sup>p. 45</sup> |
|||
* Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). <sup>p. 45</sup> |
|||
=== Sustainability Performance & Ratings === |
=== Sustainability Performance & Ratings === |
||
| Line 1,929: | Line 1,958: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ ESG |
|+ ESG Ratings and Scores, 2025 <sup>p. 46</sup> |
||
! style="text-align:left" | Rating |
! style="text-align:left" | Rating Agency |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | Metric |
||
! class="col-m" style="text-align:right" | 2025 Result |
|||
|- |
|- |
||
| style="text-align:left" | S&P Global |
| style="text-align:left" | S&P Global |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | Percentile in Dow Jones Best-in-Class Europe & World indices |
||
| class="col-m" style="text-align:right" | 97th |
|||
|- |
|- |
||
| style="text-align:left" | S&P Global |
| style="text-align:left" | S&P Global |
||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | AAA |
| class="col-m" style="text-align:right" | AAA |
||
|- |
|- |
||
| style="text-align:left" | MSCI |
| style="text-align:left" | MSCI |
||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | AAA |
| class="col-m" style="text-align:right" | AAA |
||
|- |
|- |
||
| style="text-align:left" | CDP |
| style="text-align:left" | CDP |
||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | B |
| class="col-m" style="text-align:right" | B |
||
|- |
|- |
||
| style="text-align:left" | Morningstar Sustainalytics |
| style="text-align:left" | Morningstar Sustainalytics |
||
| class="col-m" style="text-align:right" | ESG Risk Rating |
|||
| class="col-m" style="text-align:right" | 17.0 - Low risk |
| class="col-m" style="text-align:right" | 17.0 - Low risk |
||
|- |
|- |
||
| style="text-align:left" | FTSE Russell |
| style="text-align:left" | FTSE Russell |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | Score in FTSE4Good Index Series |
||
| class="col-m" style="text-align:right" | 4.3/5 |
|||
|} |
|} |
||
</div> |
</div> |
||
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>. |
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>. |
||
* Results as of February 6th, 2026 <sup>p. 46</sup>. |
* Results as of February 6th, 2026 <sup>p. 46</sup>. |
||
| Line 1,964: | Line 2,001: | ||
** China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>. |
** China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>. |
||
** '''Africa''': Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>. |
** '''Africa''': Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>. |
||
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>. |
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>. |
||
** Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>. |
|||
** AXA Mediterranean Holdings <sup>p. 47</sup>. |
** AXA Mediterranean Holdings <sup>p. 47</sup>. |
||
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>. |
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>. |
||
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>. |
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>. |
||
* Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>. |
* Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>. |
||
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>. |
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>. |
||
| Line 1,980: | Line 2,016: | ||
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>. |
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>. |
||
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) <sup>p. 48</sup>. |
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) <sup>p. 48</sup>. |
||
* |
* Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>. |
||
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. |
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>. |
||
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>. |
|||
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>. |
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>. |
||
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>. |
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>. |
||
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. |
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. Operating variance is net of reinsurance <sup>p. 48</sup>. |
||
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>. |
|||
** Operating variance is net of reinsurance <sup>p. 48</sup>. |
|||
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>. |
|||
** PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>. |
|||
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>. |
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>. |
||
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>. |
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>. |
||
| Line 2,000: | Line 2,033: | ||
== Abbreviations == |
== Abbreviations == |
||
* '''AA''': |
* '''AA''': Senior bond rating |
||
* '''AAA''': |
* '''AAA''': Senior bond rating |
||
* '''ABS''': Asset-Backed Securities |
* '''ABS''': Asset-Backed Securities |
||
* '''AEP''': Aggregate Exceedance Probability |
* '''AEP''': Aggregate Exceedance Probability |
||
* '''AI''': Artificial Intelligence |
* '''AI''': Artificial Intelligence |
||
* '''AMF''': Autorité des |
* '''AMF''': Autorité des marchés financiers |
||
* '''APAC''': Asia-Pacific |
* '''APAC''': Asia-Pacific |
||
* '''AXA IM''': AXA Investment Managers |
|||
* '''AXA UK''': AXA United Kingdom |
|||
* '''AXA XL''': AXA XL (AXA's corporate and specialty risk division) |
|||
* '''AY''': Accident Year |
* '''AY''': Accident Year |
||
* '''BBA''': |
* '''BBA''': Benefit-Bearing Assets |
||
* '''BNP''': Banque Nationale de Paris |
* '''BNP''': Banque Nationale de Paris |
||
* '''CDP''': Carbon Disclosure Project |
* '''CDP''': Carbon Disclosure Project |
||
| Line 2,015: | Line 2,051: | ||
* '''CSA''': Corporate Sustainability Assessment |
* '''CSA''': Corporate Sustainability Assessment |
||
* '''CSM''': Contractual Service Margin |
* '''CSM''': Contractual Service Margin |
||
* '''CY''': |
* '''CY''': Calendar Year |
||
* '''DPS''': Dividend Per Share |
* '''DPS''': Dividend Per Share |
||
* '''EME''': Emerging Markets |
* '''EME''': Emerging Markets |
||
| Line 2,027: | Line 2,063: | ||
* '''FX''': Foreign Exchange |
* '''FX''': Foreign Exchange |
||
* '''GAAP''': Generally Accepted Accounting Principles |
* '''GAAP''': Generally Accepted Accounting Principles |
||
* '''GEP''': Gross Earned |
* '''GEP''': Gross Earned Premiums |
||
* '''GF |
* '''GF''': Grandfathered |
||
* '''GF GBP''': Group Funds Great British Pound |
|||
* '''GWP''': Gross Written Premiums |
* '''GWP''': Gross Written Premiums |
||
* '''HKD''': Hong Kong Dollar |
* '''HKD''': Hong Kong Dollar |
||
| Line 2,051: | Line 2,086: | ||
* '''PVEP''': Present Value of Expected Profits |
* '''PVEP''': Present Value of Expected Profits |
||
* '''PYD''': Prior Years' Reserve Development |
* '''PYD''': Prior Years' Reserve Development |
||
* '''RCG''': Reinsurance Commission and |
* '''RCG''': Reinsurance Commission and Fees |
||
* '''ROE''': Return |
* '''ROE''': Return on Equity |
||
* '''SCR''': Solvency Capital Requirement |
* '''SCR''': Solvency Capital Requirement |
||
* '''SHE''': Shareholders' Equity |
* '''SHE''': Shareholders' Equity |
||
* '''SME''': Small and Medium-sized Enterprises |
* '''SME''': Small and Medium-sized Enterprises |
||
* '''TVOG''': Time Value of Options |
* '''TVOG''': Time Value of Options and Guarantees |
||
* '''UEPS''': Underlying Earnings Per Share |
* '''UEPS''': Underlying Earnings Per Share |
||
* '''UK''': United Kingdom |
* '''UK''': United Kingdom |
||
Revision as of 15:09, 21 June 2026
| Document info | |
|---|---|
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document type | Analyst presentation |
| Publication date | 2026-02-26 |
| Language | English |
| Pages | 49 |
| Source | Original URL |
| Archive file | .md file |
This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
Front matter
Full Year 2025 earnings presentation
- Full Year 2025 Earnings Presentation p. 1
- February 26, 2026 p. 1
Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures
- Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives p. 2.
- Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' p. 2.
- Statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking, providing one-off guidance for the last year of the Group's current strategic plan p. 2.
- These statements are based on Management's current views and intentions and are subject to change p. 2.
- Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA's control p. 2.
- Factors could cause AXA's actual results to differ materially from those expressed or implied p. 2.
- Each forward-looking statement speaks only at the date of this presentation p. 2.
- Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties p. 2.
- AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations p. 2.
- This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and position p. 2.
- These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies p. 2.
- Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS p. 2.
- Underlying earnings, UEPS ('underlying earnings per share'), underlying return on equity, combined ratio, and debt gearing are APMs as defined in ESMA's guidelines and AMF's related position statement issued in 2015 p. 2.
- AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' p. 2.
- For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report p. 2.
- AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) p. 2.
- AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors p. 2.
Table of contents
- 1. FY25 Highlights: presented by Thomas Buberl, Group CEO, starting on p.04 p. 3.
- 2. FY25 Business Performance: presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on p.09 p. 3.
- 3. FY25 Financial Performance: presented by Alban de Mailly Nesle, Group CFO, starting on p.13 p. 3.
FY25 Highlights
- Presented by Thomas Buberl, Group CEO p. 4.
Full Year 2025 | Excellent performance
- Revenues +6% vs. FY24 p. 5
- ROE 16% in FY25 p. 5
- Underlying EPS +8% vs. FY24 p. 5
- Solvency II ratio 224% in FY25 p. 5
- Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual share buyback p. 5
- Dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by Shareholders' Annual General Meeting on April 30, 2026 p. 5.
- Share buyback approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions p. 5.
- Confident to deliver underlying EPS growth at the upper end of 6%-8% target range for 2026 p. 5
Executing the plan on growth, margin and efficiency
| EUR billion | FY24 | FY25 |
|---|---|---|
| Underlying earnings | 8.1 | 8.4 |
- Underlying earnings +6% p. 6
- High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) p. 6
- Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency p. 6
- Scaling the business: Continued investments in growth and technology p. 6
- Consistent earnings growth while enhancing reserve prudence p. 6
- Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX p. 6
Diversified franchise, well positioned in an attractive industry
| Segment | Share |
|---|---|
| Life | 33% |
| Health | 17% |
| Large & Specialty | 17% |
| SME & Mid-market | 16% |
| Retail | 17% |
- Secular trends fueling demand across businesses p. 7
- Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) p. 7
- Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) p. 7
- Our right to win p. 7
- Leading brand & high customer NPS p. 7
- Strong and diversified distribution p. 7
- Technical expertise to price & underwrite risks p. 7
- Scale offering cost advantage p. 7
Laying the foundation for the next plan
- (icon) Clear tech and AI roadmap p. 8
- (icon) Driving efficiency p. 8
- (icon) Enhancing capital allocation discipline p. 8
- (icon) Building resilience p. 8
- Confidence in sustaining earnings growth p. 8
FY25 Business Performance
- Guillaume Borie p. 9
- Global Head of Finance, Strategy, Underwriting, Risk, and Technology p. 9
Strong delivery across our businesses
| EUR billion unless otherwise mentioned | GWP | GWP change | Underlying earnings | Underlying earnings change | % of total GWP |
|---|---|---|---|---|---|
| France | 31 | +6% | 2.2 | +7% | 27% |
| Europe | 43 | +6% | 3.5 | +9% | 38% |
| AXA XL | 19 | +4% | 1.9 | +9% | 17% |
| Asia, Africa & EME-LATAM | 20 | +13% | 1.5 | +6% | 18% |
- Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX
- ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers
P&C | Strong margins, confidence in sustaining growth
| Segment | Share |
|---|---|
| Retail | 34% |
| SME & Mid-market | 33% |
| AXA XL (Large & Specialty) | 33% |
- Underlying earnings +9% (FY25 vs. FY24 at constant FX) to EUR 5.9bn
- Includes AXA XL Re premiums of EUR 2.6bn
- 2025 Strategic Focus
- Retail and SME & Mid-market: Growing volumes while expanding margins
- AXA XL (Large & Specialty): Profitable growth with stable margins
- Beyond 2025 Strategic Focus
- Retail and SME & Mid-market: Investing to improve customer retention & expanding distribution footprint
- AXA XL (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management
- Additional Strategic Initiatives
- Continued progress on efficiency
- Higher investment income
- Data & AI to further enhance customer experience & technical excellence
L&H | Good momentum, well positioned to capture growth opportunities
| Segment | Share |
|---|---|
| Short-term | 28% |
| Long-term | 72% |
- Underlying earnings +7% (FY25 vs. FY24 at constant FX) to EUR 3.5bn
- 2025 Strategic Focus
- Long-term business: Accelerating net flows in Savings at attractive margins
- Short-term business: Growing technical results while absorbing Mexico VAT impact
- Beyond 2025 Strategic Focus
- Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for our customers
- Short-term business: Capitalizing on demand for health & protection while further improving our margins
- Additional Strategic Initiatives
- Focus on cost reduction
- Increasing penetration of Protection riders in Savings offerings
- Leveraging AI to reduce claims leakage & improve customer outcomes in Health
FY25 Financial Performance
- FY25 Financial Performance p. 13
- Alban de Mailly Nesle, Group CFO p. 13
P&C | Continued disciplined growth
| EUR billion unless otherwise mentioned | FY24 | FY25 |
|---|---|---|
| Commercial lines | 35.8 | 35.8 |
| AXA XL Reinsurance | 2.6 | 2.6 |
| Retail lines | 18.1 | 19.7 |
| Total | 56.5 | 58.0 |
| Segment | Change | Pricing | Volume |
|---|---|---|---|
| Commercial lines | +4% | +2% | +2% |
| AXA XL Reinsurance | +8% | +0.3% | +7% |
| Retail lines | +7% | +5% | +2% |
- Continued pricing momentum and volume growth in Mid-market and SME
- Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
- Growth supported by alternative capital
- Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
- (table) Change at constant scope and FX p. 14
P&C | Delivering further margin expansion while enhancing reserve prudence
| — | FY24 | FY25 |
|---|---|---|
| Undiscounted CY loss ratio (ex Nat Cat) | 67.4% | 67.0% |
| Expense ratio | 25.0% | 24.8% |
| Nat Cat | 3.8% | 3.4% |
| Prior year reserve development | -1.6% | -1.1% |
| Discount | -3.6% | -3.5% |
| Total Combined Ratio | 91.0% | 90.6% |
- Better undiscounted current year loss ratio excluding Nat Cat from:
- Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
- Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
- Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
- Nat Cat charges below normalized load
- Lower reliance on prior year reserve development
- Taking advantage of a good year to enhance reserve prudence
P&C | Earnings growth from higher underwriting and financial result
| EUR million | Underlying Earnings |
|---|---|
| FY24 | 5,510 |
| Volume growth | +292 |
| Margin improvement | +189 |
| Investment income | +435 |
| Insurance finance expenses | -235 |
| Tax | -169 |
| Affiliates, FX & other | -150 |
| FY25 | 5,872 |
- Underlying Earnings +9% (constant FX)
- Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
- Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets
- Higher unwind of discount of claims reserves, in line with guidance
- Unfavorable forex impact notably due to USD depreciation vs. EUR
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| Life GWP & Other Revenues | 34.5 | 37.5 | +9% |
| Protection | 17.3 | 19.0 | +11% |
| Unit-linked | 9.3 | 10.5 | +13% |
| Capital light G/A | 6.0 | 6.1 | +7% |
| Traditional G/A | 1.9 | 1.9 | -7% |
| Health GWP & Other Revenues | 17.5 | 19.0 | +5% |
| Individual | 10.5 | 11.1 | +6% |
| Group | 7.0 | 7.9 | +4% |
| EUR billion | Net flows |
|---|---|
| Protection | +4.9 |
| Health | +2.7 |
| Unit-Linked | +1.5 |
| Capital light G/A | +1.2 |
| Traditional G/A | -5.0 |
- Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24
- Employee Benefits (short-term and long-term) FY25: EUR 12.9bn (+4% vs. FY24)
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| PVEP | 50.9 | 49.4 | -2% |
| Protection & Health | 39.4 | 31.4 | -4% |
| Unit-Linked | 8.5 | 8.5 | +18% |
| Capital-light G/A | 2.0 | 7.8 | -10% |
| Traditional G/A | 1.0 | 1.7 | -10% |
| EUR billion unless otherwise mentioned | FY24 | FY25 |
|---|---|---|
| NB CSM (pre-tax) | 2.2 | 2.2 |
| NBV (post-tax) | 2.3 | 2.2 |
| NBV margin | 4.4% | 4.5% |
- PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes
- NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits
- NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France
- (bar) NB CSM (pre-tax) +3% (constant scope and FX) p. 18
Life & Health | Growth in new business driving Normalized CSM growth
| EUR billion | Contractual Service Margin |
|---|---|
| FY24 | 33.6 |
| New business CSM | +2.2 |
| Underlying return on in-force | +1.3 |
| CSM release | -3.0 |
| Economic variance | +0.6 |
| Operating variance | -0.3 |
| Affiliates, FX & other | -1.4 |
| FY25 | 33.0 |
| EUR billion | FY24 | FY25 |
|---|---|---|
| Life | 25.8 | 25.4 |
| Health | 7.7 | 7.6 |
- Normalized CSM up by +2% (constant scope and FX), with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
- Economic variance reflecting government spreads tightening and positive equity market returns
- Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
- FX impact mainly from JPY and HKD depreciation
Life & Health | Strong momentum in both short-term and long-term business
| EUR million | Underlying earnings |
|---|---|
| FY24 | 3,323 |
| Short-term technical margin | +60 |
| Long-term result incl. CSM release | +156 |
| Financial result | -11 |
| Tax, FX and others | -27 |
| FY25 | 3,501 |
- Underlying Earnings +7% (constant FX) p. 20
- Strong short-term technical margin reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) p. 20
- Higher long-term results from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins p. 20
- Underlying Earnings by segment:
- Life: FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) p. 20
- Health: FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) p. 20
- Short-term technical margin: EUR 479m p. 20
- Long-term result incl. CSM release: EUR 2,804m p. 20
- Financial result: EUR 946m p. 20
- Tax & others: -EUR 728m p. 20
Growth in net income reflecting higher earnings & the gain from the sale of AXA IM
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| Underlying earnings | — | — | +6% |
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | - |
| Underlying earnings total | 8.1 | 8.4 | +6% |
| Net income | — | — | +26% |
| Non-financial flows | -0.5 | 2.1 | — |
| o/w capital gains from AXA IM disposal | - | 2.2 | — |
| Financial flows (incl. RCG) | 0.3 | -0.7 | — |
| Net income total | 7.9 | 9.8 | +26% |
| EUR | Underlying earnings per share |
|---|---|
| FY24 | 3.59 |
| Earnings growth | +6% |
| Capital management | +3% |
| Forex | -2% |
| FY25 | 3.86 |
- Underlying earnings: Strong performance from insurance businesses p. 21
- Underlying earnings: Stable holding cost, expected to remain at current level in 2026 p. 21
- Net income: Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM p. 21
- Net income: Lower financial flows reflecting unfavorable forex impact p. 21
- Change at constant FX for underlying earnings and net income p. 21
- Change on reported basis for underlying earnings per share p. 21
- (bar) Underlying earnings per share: EUR 3.59 (FY24) → EUR 3.86 (FY25) (+8%) p. 21
- including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback p. 21
| EUR billion unless otherwise mentioned | FY24 | HY25 | FY25 |
|---|---|---|---|
| SHE (excl. OCI) | 58.0 | 52.7 | 54.0 |
| Net OCI | -8.1 | -7.2 | -6.8 |
| SHE (excl. OCI & undated subordinated debt) | 53.2 | 47.0 | 49.4 |
| Debt gearing | 20.6% | 23.4% | 22.3% |
| Underlying ROE | 15.2% | 17.5% | 16.0% |
| EUR billion | FY24 to FY25 | HY25 to FY25 |
|---|---|---|
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | 1.3 | 0.4 |
| Net income for the period | 9.8 | 5.9 |
| Dividend | -4.6 | - |
| Annual share buyback | -1.2 | - |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 | -3.5 |
| Undated subordinated debt (including interest charges) | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | 0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |
- 1. Shareholders' equity Group share p. 22
- Shareholders' equity reconciliation (in Euro billion) p. 22
Higher organic cash remittance and robust cash position at Holding
| EUR billion unless otherwise mentioned | FY24 | FY25 |
|---|---|---|
| Net Cash Remittance | 7.7 | 7.5 |
| Remittance ratio | 82% | 82% |
| Cash position | 4.0 | 5.6 |
- FY24 Net Cash Remittance includes EUR 7.1bn (base) and EUR 0.6bn Proceeds related to in-force treaties².
- Net cash remittance from subsidiaries: +EUR 7.5bn
- Dividend: -EUR 4.6bn
- Annual share buyback: -EUR 1.2bn
- Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn
- Holding costs and interest expenses: -EUR 1.3bn
- Change in net debt: +EUR 1.6bn
- M&A and other: +EUR 3.1bn
- 1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25
- 2. EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe
Solvency II at 224%
| EUR billion unless otherwise mentioned | Eligible Own Funds (EOF) | Solvency Capital Requirement (SCR) | Solvency II ratio (pts) |
|---|---|---|---|
| FY24 | 55.9 | 25.9 | 216 |
| Regulatory & model changes | +0.2 | 0.0 | +0 |
| Normalized capital generation | +8.8 | +0.6 | +28 |
| Operating variance | -0.4 | 0.0 | -1 |
| Economic & FX | -2.1 | -1.2 | +4 |
| Dividend & annual share buyback | -6.0 | 0.0 | -24 |
| Management actions, debt & other | -0.1 | -0.2 | +2 |
| FY25 | 56.4 | 25.2 | 224 |
| Sensitivity | Impact (pts) |
|---|---|
| Interest rate +50bps | +2 |
| Interest rate -50bps | -1 |
| Corporate spreads +50bps | -1 |
| Euro Sovereign spreads +50bps | -7 |
| Credit migration | -4 |
| Listed Equity (excl. PE & Infra) +25% | -1 |
| Listed Equity (excl. PE & Infra) -25% | +2 |
| PE & Infra +25% | +14 |
| PE & Infra -25% | -19 |
| Inflation swap curve +50bps | -5 |
- Dividend & annual share buyback: Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn
- 1. Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures)
- 2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches)
Solvency II -impact of the end of grandfathering period and Solvency II revision
| Item | Value |
|---|---|
| Ratio as of 31/12/2025 | 224% |
| Impact of the end of grandfathering period on January 1, 2026 | -10pts to 215% |
| Impact of Solvency II revision to come into effect in 1Q27 | +17pts |
- Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026
- No change expected in organic capital generation
- Additional capital flexibility
- 1. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date
Thomas Buberl, Group CEO conclusion
- Conclusion p. 26
- Thomas Buberl, Group CEO p. 26
Conclusion
- Record results, at the top end of the target range while enhancing reserve prudence p. 27
- All businesses in excellent shape, delivering strong growth and profitability p. 27
- Diversified franchise, well-positioned to capture future growth opportunities p. 27
- Laying foundations for the next plan and confident in delivering sustainable earnings growth p. 27
February 26, 2026 Q&A Full Year 2025 earnings
- Q&A p. 28
- Full Year 2025 Earnings p. 28
- February 26, 2026 p. 28
AXA Investor Relations | Keep in touch
- Contact us: p. 29
- Investor Relations +33 1 40 75 48 42 p. 29
- investor.relations@axa.com p. 29
- Follow us: www.axa.com p. 29
- Upcoming events: p. 29
- March: Roadshows in Europe and US p. 29
- May 5: 1Q25 Activity Indicators in Paris p. 29
- June 2: BNP Paribas Exane CEO Conference in Paris p. 29
- June 2-4: Goldman Sachs European Financials Conference in Zurich p. 29
- July 31: HY26 Earnings Release in Paris p. 29
- September 21: AXA Investor Day in London p. 29
Appendices
- Appendices p. 30
- Debt and Invested Assets p. 31
- Additional P&C disclosures p. 36
- Additional IFRS17 disclosures p. 41
- Sustainability p. 44
Gross financial debt and maturity breakdown as of December 31st, 2025
| EUR billion | Tier 1 | Tier 2 | Senior debt | Total |
|---|---|---|---|---|
| FY24 | 3.5 | 10.8 | 4.8 | 19.2 |
| FY25 | 3.5 | 12.2 | 4.6 | 22.3 |
| Jan 1st 2026 | 5.8 | 11.3 | 3.2 | 20.3 |
| EUR billion | Senior debt | Tier 2 | Tier 1 |
|---|---|---|---|
| 2025 | 0.5 | 0.5 | 0.5 |
| 2026 | 0.9 | 0.9 | 0.5 |
| 2027 | 0.5 | 0.5 | 0.5 |
| 2028 | 0.9 | 0.9 | 0.5 |
| 2029 | 0.9 | 0.9 | 0.5 |
| 2030 | 0.9 | 0.9 | 0.5 |
| 2031-2039 | 0.9 | 0.9 | 0.5 |
| ≥2040 | 10.8 | 0.2 | 1.4 |
| Undated | 4.6 | 0.7 | 0.5 |
| EUR billion | Tier 1 | Tier 2 |
|---|---|---|
| 2031-2039 | 0.7 | 0.2 |
| ≥2040 | 0.2 | — |
| Undated | 0.5 | — |
| EUR billion | Senior debt | Tier 2 | Tier 1 |
|---|---|---|---|
| 2025 | 0.1 | 0.1 | 0.1 |
| 2026 | 0.1 | 0.1 | 0.1 |
| 2027 | 2.4 | 0.1 | 0.1 |
| 2028 | 2.0 | 0.1 | 0.1 |
| 2029 | 0.9 | 0.1 | 0.1 |
| 2030 | 0.7 | 0.1 | 0.1 |
| 2031-2039 | 6.4 | 0.2 | 1.5 |
| ≥2040 | 0.5 | 0.1 | 0.7 |
| Undated | 4.0 | 0.1 | 0.7 |
| EUR billion | Tier 1 | Tier 2 |
|---|---|---|
| 2031-2039 | 0.7 | 0.2 |
| ≥2040 | 0.2 | — |
| Undated | 0.8 | — |
- Debt gearing: FY24 20.6%; FY25 22.3% p. 32
- In January 2026, AXA called the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 p. 32
- In January 2026, AXA called the T1 GF €250m perpetual callable 2010 floating issued January 2005 p. 32
- Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt p. 32
- For Solvency 2 RT1 debt, the undated nature of the instrument is retained for this diagram, as it has no step-up p. 32
- Jan 1st 2026 (End of the grandfathering period): Total 20.3; Tier 1 5.8 (o/w EUR 0.4bn redeemed in Jan 2026); Tier 2 11.3; Senior debt 3.2 p. 32
General Account invested assets
| EUR billion unless otherwise mentioned | Share | |
|---|---|---|
| Fixed income | 345 | 77% |
| Real estate | 41 | 9% |
| Infrastructure equity | 10 | 2% |
| Listed equities | 10 | 2% |
| Private equity and hedge funds | 23 | 5% |
| Cash | 19 | 4% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets | 450 | 100% |
- Duration gap: -0.4 year p. 33
- o/w Government bonds: 167 (37%) p. 33
- o/w Corporate bonds and loans: 121 (27%) p. 33
- o/w Other fixed income: 56 (13%) p. 33
- Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) p. 33
- Listed equities includes hedges; listed equities excluding hedges at EUR 14bn p. 33
- Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) p. 33
- Refer to the financial supplement for more details p. 33
Structured and Private Credit assets
| EUR billion unless otherwise mentioned | % of total G/A portfolio | |
|---|---|---|
| Residential Mortgages | 16 | 4% |
| CLO & ABS | 25 | 6% |
| Infrastructure debt | 8 | 2% |
| CRE debt | 8 | 2% |
| Mid-Market lending | 10 | 2% |
| Other | 2 | 0% |
| Total Structured and Private Credit Assets | 69 | 15% |
- EUR 6bn Dutch mortgages, NHG guaranteed p. 34
- EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) p. 34
- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 93% rated AAA-AA) p. 34
- Skewed towards resilient industries (Telecom, Utilities, Transport) p. 34
- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV p. 34
- Strong diversification with EUR 8m average ticket p. 34
- Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation p. 34
- o/w 54% participating p. 34
- G/A: General Account p. 34
Investment portfolio | Fixed Income reinvestment
| Segment | Share | Average rating | Yield |
|---|---|---|---|
| Government bonds & related | 32% | AA | 3.5% |
| Investment grade credit | 40% | A | — |
| ABS/CLO/IG fund financing | 21% | — | — |
| Below investment grade credit | 7% | — | — |
| Public fixed income | — | — | 3.5% |
| Private & Structured fixed income | — | — | 4.7% |
| Total fixed income | — | — | 3.9% |
- EUR 57 billion fixed income invested at 3.9% p. 35
- Average duration of 9 years p. 35
- Includes EUR 19.7 billion of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) p. 35
- Gradual shift from alternative total return assets to Private & Structured credit p. 35
- Government and Corporate bonds and related p. 35
- Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) p. 35
- Table of contents:
- 1. Debt and Invested Assets, p.31 p. 36
- 2. Additional P&C disclosures, p.36 p. 36
- 3. Additional IFRS17 disclosures, p.41 p. 36
- 4. Sustainability, p.44 p. 36
AXA XL Insurance | Large Commercial & Specialty business
| Segment | Line of business share | Geography share |
|---|---|---|
| Casualty | 35% | — |
| Property | 29% | — |
| Specialty | 19% | — |
| Professional lines | 17% | — |
| Americas | — | 46% |
| Europe & APAC | — | 35% |
| UK & Lloyds | — | 19% |
- Well diversified across lines of business and geographies p. 37
- Leading market positions across lines p. 37
- Top 3 globally p. 37
- Multinational Programs p. 37
- Marine p. 37
- Fine Art & Specie p. 37
- Managing the cycle to deliver consistent profitability p. 37
- (scatter plot) Profitability vs. Ex-price growth (%):
- Property (high profitability, high ex-price growth) p. 37
- Specialty (medium profitability, medium ex-price growth) p. 37
- Casualty (medium profitability, low ex-price growth) p. 37
- Professional lines (low profitability, low ex-price growth) p. 37
- (scatter plot) Profitability vs. Ex-price growth (%):
P&C | Focus on Reserves
| % | Claims reserves ratio (IFRS4) | Claims reserves ratio (IFRS17) | Technical reserves ratio (IFRS4) | Technical reserves ratio (IFRS17) |
|---|---|---|---|---|
| FY18 | 179% | — | 213% | — |
| FY19 | 185% | — | 227% | — |
| FY20 | 193% | — | 233% | — |
| FY21 | 188% | — | 226% | — |
| FY22 | 189% | 198% | 227% | 234% |
| FY23 | — | 195% | — | 232% |
| FY24 | — | 180% | — | 216% |
| FY25 | — | 175% | — | 210% |
- Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) p. 38
- Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) p. 38
P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1
| EUR billion | Capacity | Retention |
|---|---|---|
| EU Windstorm | 4.0 | 600m |
| Europe Flood | 2.1 | 450m |
| Europe Earthquake | 2.1 | 400m |
| NA Hurricane | 1.2 | 600m |
| NA Earthquake | 1.2 | 600m |
| Per other perils | 1.0 | 400m |
- Stable retention levels maintained in 2026 as in 2025
- (diagram) Reinsurance segment (illustrative): Alternative Capital & Cat Bonds
- Footnote 1: Excludes local reinsurance covers
- Footnote 2: Varying retention between MX and NA (EUR 400m MX, EUR 600m NA)
- Footnote 3: Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.
P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026
| Percentile | Deviation |
|---|---|
| 1/20y (95th percentile) | -EUR 1.2bn |
| 1/10y (90th percentile) | -EUR 0.8bn |
| 1/5y (80th percentile) | -EUR 0.4bn |
| Median (50th percentile) | EUR 0.1bn |
| 1/5y (20th percentile) | EUR 0.5bn |
| 1/10y (10th percentile) | EUR 0.7bn |
| 1/20y (5th percentile) | EUR 0.8bn |
| EUR billion | 2025 | 2026 |
|---|---|---|
| Average Expected Nat Cat charges | 2.6 | 2.7 |
| Estimated impact on GEP | 4.5% | 4.5% |
- Footnote 1: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
- (bar) More severe years (Negative deviation in ca. 40% of cases):
- (bar) Less severe years (Positive deviation in ca. 60% of cases):
- Table of contents p. 41
- 1. Debt and Invested Assets p. 31
- 2. Additional P&C disclosures p. 36
- 3. Additional IFRS17 disclosures p. 41
- 4. Sustainability p. 44
P&C | Margin analysis
| EUR million unless otherwise mentioned | FY25 | Change |
|---|---|---|
| Technical Result | — | — |
| Current Accident Year Undiscounted Technical Margin | 2,778 | +707 |
| Gross Earned Premiums | 57,656 | +6% |
| Current Accident Year Undiscounted Combined Ratio | 95.2% | -1.0pt |
| o/w Nat Cats | 3.4% | -0.4pt |
| Current Accident Year Discounting | 2,009 | +115 |
| Discounting Ratio (in Combined Ratio points) | -3.5% | +0.0pt |
| Current Accident Year Net Claims reserves | 19.0bn | — |
| Duration | 4.0 years | — |
| Current Accident Year Discount Rate | 2.8% | — |
| Prior Years' Reserve Development (PYD) | 622 | -341 |
| PYD ratio | -1.1% | +0.7pt |
| Financial Result | — | — |
| Investment Income | 3,988 | +435 |
| FY25 Average Assets | 115bn | — |
| Asset book yield | 3.5% | — |
| FY25 Reinvestment yield | 4.3% | — |
| Insurance Finance Expenses | -1,358 | -235 |
| FY24 Reserves at locked-in rate | 71bn | — |
| Liability book yield | 1.9% | — |
| 2025 Insurance Finance Expenses (pre-tax) | ~-1.4bn | — |
| Underlying Earnings before tax | 8,040 | +681 |
| Tax | -2,060 | -169 |
| Affiliates, Minority interests & Other | -108 | -10 |
| Underlying Earnings | 5,872 | +501 |
| Growth vs. FY24 (at constant FX) | +9% | — |
| EUR billion | Impact |
|---|---|
| +25bps | +0.2 |
| -25bps | -0.2 |
| EUR million | Impact |
|---|---|
| +25bps | ~-50 |
| -25bps | ~+50 |
- Changes versus FY24 at constant FX p. 42
- Reinvestment yield on fixed income assets p. 42
- Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve p. 42
- (flow) Technical Result (In Euro million, pre-tax) p. 42
- (flow) Financial Result (In Euro million, pre-tax) p. 42
- (flow) Underlying Earnings before tax p. 42
L&H | Margin analysis
| EUR million unless otherwise mentioned | FY25 | Change |
|---|---|---|
| Technical Result | — | — |
| Short-term Technical Margin | 479 | +60 |
| Gross Earned Premiums | 17,416 | +10% |
| All Year Combined Ratio | 97.2% | -0.1pts |
| Long-term Technical Margin | 2,804 | +156 |
| CSM release | 2,954 | +215 |
| Technical experience | -150 | -58 |
| Financial Result | — | — |
| Investment Income (non-VFA only) | 2,484 | -1 |
| FY25 Average Assets | 98bn | — |
| Asset book yield | 2.5% | — |
| FY25 Reinvestment yield | 3.8% | — |
| Insurance Finance Expenses (non-VFA only) | -1,538 | -9 |
| FY24 Reserves at locked-in rate | 62bn | — |
| Liability book yield | 2.5% | — |
| Underlying Earnings before tax | 4,229 | +205 |
| Tax | -800 | +65 |
| Affiliates, Minority interests & Other | 72 | -51 |
| Underlying Earnings | 3,501 | +219 |
| Growth vs. FY24 (at constant FX) | +7% | — |
| EUR billion | Value |
|---|---|
| Baseline | 33.3 |
| Interest rates +50bps | -0.8 |
| Interest rates -50bps | 0.6 |
| Sovereign spreads +50bps | -1.9 |
| Sovereign spreads -50bps | 1.9 |
| Corporate spread +50bps | -0.8 |
| Corporate spread -50bps | 0.8 |
| Equities +25% | 1.8 |
| Equities -25% | -2.2 |
| EUR billion | Value | % of total G/A portfolio |
|---|---|---|
| Residential Mortgages | 16 | 4% |
| CLO & ABS | 25 | 6% |
| Infrastructure debt | 8 | 2% |
| CRE debt | 8 | 2% |
| Mid-Market lending | 10 | 2% |
| Other | 2 | 0% |
| Total Structured and Private Credit Assets | 69 | 15% |
- Includes scope impact p. 43
- Changes versus FY24 at constant FX p. 43
- Reinvestment yield on fixed income assets p. 43
- Incl. recapture of Laya p. 43
- EUR 6bn Dutch mortgages, NHG guaranteed p. 43
- EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) p. 43
- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) p. 43
- Skewed towards resilient industries (Telecom, Utilities, Transport) p. 43
- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV p. 43
- Strong diversification with EUR 8m average ticket p. 43
- Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation p. 43
- o/w 54% participating p. 43
- (flow) Technical Result (In Euro million, pre-tax) p. 43
- (flow) Financial Result (In Euro million, pre-tax) p. 43
- (flow) Underlying Earnings before tax p. 43
- Table of contents p. 44
- 1. Debt and Invested Assets p. 31
- 2. Additional P&C disclosures p. 36
- 3. Additional IFRS17 disclosures p. 41
- 4. Sustainability p. 44
Expanding AXA's role in society: AXA for Progress Index 1
| — | Target | 2025 Result |
|---|---|---|
| As a Global INVESTOR | — | — |
| Climate transition financing | EUR 5bn per year | EUR 6.4bn |
| Community resilience financing | EUR 500m per year | EUR 1.4bn |
| As a Global INSURER | — | — |
| P&C GWP to support transition underwriting (cumulative 2024-2026) | EUR 6bn | EUR 4.6bn |
| Climate adaptation solutions & services (cumulative 2024-2026) | >20,000 | 19,698 Cumulative 2024-2025 |
| Inclusive insurance customers by 2026 | >20m | 20.6m |
| As a COMPANY | — | — |
| AXA Group employees trained on climate adaptation by 2026 | >80,000 | 46,420 |
| Contribute to Net-Zero in absolute carbon emissions by 2030 | -50% by 2030 | -64% Reduction against 2019 |
| Percentage of AXA Group employees engaged in volunteering activities by 2026 | 50% | 56% |
- AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 p. 45
- Scope: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 p. 45
- Scope: AXA France, AXA Germany, AXA Switzerland, AXA XL, AXA Hong Kong, AXA Japan, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 p. 45
- Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include: (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in the target for the 2024-2026 period, from >9,000 to >20,000 p. 45
- Inclusive insurance includes underserved populations and markets and modest income segments in mature markets p. 45
- Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 p. 45
- Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 p. 45
- Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) p. 45
- Target revised in 2025 p. 45
Sustainability Performance & Ratings
| Rating Agency | Metric | 2025 Result |
|---|---|---|
| S&P Global | Percentile in Dow Jones Best-in-Class Europe & World indices | 97th |
| S&P Global | Score | AAA |
| MSCI | Score | AAA |
| CDP | Score | B |
| Morningstar Sustainalytics | ESG Risk Rating | 17.0 - Low risk |
| FTSE Russell | Score in FTSE4Good Index Series | 4.3/5 |
- The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) p. 46.
- Results as of February 6th, 2026 p. 46.
Scope
- France: includes insurance activities, banking activities and holding p. 47.
- Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities) and AXA Life Europe (insurance activities) p. 47.
- AXA XL: includes insurance and reinsurance activities and holding p. 47.
- Asia, Africa & EME-LATAM: p. 47
- Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated p. 47.
- China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income p. 47.
- Africa: Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated p. 47.
- EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income p. 47.
- AXA Mediterranean Holdings p. 47.
- Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings p. 47.
- AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method p. 47.
- Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 p. 47.
- Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 p. 47.
Glossary
- Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% p. 48.
- Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders p. 48.
- CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period p. 48.
- Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force p. 48.
- Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow p. 48.
- Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) p. 48.
- Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) p. 48.
- New Business Value (NBV): the value of newly issued contracts during the current year p. 48. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests p. 48.
- New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided p. 48.
- New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP p. 48.
- Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes p. 48. Operating variance is net of reinsurance p. 48.
- Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term p. 48. PVEP is discounted at the reference interest rate and PVEP is Group share p. 48.
- Technical experience: consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses p. 48.
- Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance p. 48.
February 26, 2026 Thank you Full Year 2025 earnings
- Thank you p. 49.
- Full Year 2025 Earnings p. 49.
- February 26, 2026 p. 49.
Abbreviations
- AA: Senior bond rating
- AAA: Senior bond rating
- ABS: Asset-Backed Securities
- AEP: Aggregate Exceedance Probability
- AI: Artificial Intelligence
- AMF: Autorité des marchés financiers
- APAC: Asia-Pacific
- AXA IM: AXA Investment Managers
- AXA UK: AXA United Kingdom
- AXA XL: AXA XL (AXA's corporate and specialty risk division)
- AY: Accident Year
- BBA: Benefit-Bearing Assets
- BNP: Banque Nationale de Paris
- CDP: Carbon Disclosure Project
- CLO: Collateralized Loan Obligation
- CRE: Commercial Real Estate
- CSA: Corporate Sustainability Assessment
- CSM: Contractual Service Margin
- CY: Calendar Year
- DPS: Dividend Per Share
- EME: Emerging Markets
- EOF: Eligible Own Funds
- EPS: Earnings Per Share
- ESG: Environmental, Social, and Governance
- ESMA: European Securities and Markets Authority
- EU: European Union
- EUR: Euro
- FTSE: Financial Times Stock Exchange
- FX: Foreign Exchange
- GAAP: Generally Accepted Accounting Principles
- GEP: Gross Earned Premiums
- GF: Grandfathered
- GWP: Gross Written Premiums
- HKD: Hong Kong Dollar
- HY: High Yield
- IFE: Insurance Finance Expenses
- IFRS: International Financial Reporting Standards
- IG: Investment Grade
- JPY: Japanese Yen
- LATAM: Latin America
- LTV: Loan-to-Value
- MSCI: Morgan Stanley Capital International
- MX: Mexico
- NA: North America
- NB CSM: New Business Contractual Service Margin
- NBV: New Business Value
- NHG: Nationale Hypotheek Garantie
- NPS: Net Promoter Score
- OCI: Other Comprehensive Income
- PAA: Premium Allocation Approach
- PE: Private Equity
- PVEP: Present Value of Expected Profits
- PYD: Prior Years' Reserve Development
- RCG: Reinsurance Commission and Fees
- ROE: Return on Equity
- SCR: Solvency Capital Requirement
- SHE: Shareholders' Equity
- SME: Small and Medium-sized Enterprises
- TVOG: Time Value of Options and Guarantees
- UEPS: Underlying Earnings Per Share
- UK: United Kingdom
- US: United States
- USD: United States Dollar
- VAT: Value Added Tax
- VFA: Variable Fee Approach